NDC00338-0409-03: LIDOCAINE HYDROCHLORIDE AND DEXT.
LIDOCAINE HYDROCHLORIDE AND DEXT. Key specifications include administration: INTRAVENOUS INFUSION, special_features: PREMIXED CONCENTRATION, primary_container_type: BAG, PLASTIC, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 18. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-148-7433, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS INFUSION |
| special_features | PREMIXED CONCENTRATION |
| primary_container_type | BAG, PLASTIC |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 18 |
| primary_container_content_quantity | 500.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| general_characteristics_item_description | LIDOCAINE HYDROCHLORIDE IN DEXTROSE INJECTION; 2 GRAMS LIDOCAINE HYDROCHLORIDE, 5% DEXTROSE, 500 ML, BAG, 18'S G |
| part_name_assigned_by_controlling_agency | LIDOCAINE HYDROCHLORIDE 500ML BAG 18S |
| NSN | 6505-01-148-7433 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| SPECIAL FEATURES | PREMIXED CONCENTRATION |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.400 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |
No substitute or cross-reference records for this part.